vs

Side-by-side financial comparison of reAlpha Tech Corp. (AIRE) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $895.3K, roughly 2.0× reAlpha Tech Corp.). INVO Fertility, Inc. runs the higher net margin — -150.5% vs -541.6%, a 391.1% gap on every dollar of revenue. On growth, reAlpha Tech Corp. posted the faster year-over-year revenue change (70.1% vs 22.6%). INVO Fertility, Inc. produced more free cash flow last quarter ($-1.8M vs $-11.3M). Over the past eight quarters, reAlpha Tech Corp.'s revenue compounded faster (562.1% CAGR vs 12.8%).

reAlpha Tech Corp is a proptech firm that leverages artificial intelligence to identify, acquire, and operate high-yield short-term residential rental properties primarily across the United States. It provides tech-powered property management solutions to enhance guest experiences and maximize returns for individual and institutional real estate investors.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

AIRE vs IVF — Head-to-Head

Bigger by revenue
IVF
IVF
2.0× larger
IVF
$1.8M
$895.3K
AIRE
Growing faster (revenue YoY)
AIRE
AIRE
+47.5% gap
AIRE
70.1%
22.6%
IVF
Higher net margin
IVF
IVF
391.1% more per $
IVF
-150.5%
-541.6%
AIRE
More free cash flow
IVF
IVF
$9.5M more FCF
IVF
$-1.8M
$-11.3M
AIRE
Faster 2-yr revenue CAGR
AIRE
AIRE
Annualised
AIRE
562.1%
12.8%
IVF

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
AIRE
AIRE
IVF
IVF
Revenue
$895.3K
$1.8M
Net Profit
$-4.8M
$-2.6M
Gross Margin
62.7%
Operating Margin
-507.8%
-93.1%
Net Margin
-541.6%
-150.5%
Revenue YoY
70.1%
22.6%
Net Profit YoY
76.9%
-62.2%
EPS (diluted)
$-0.02
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIRE
AIRE
IVF
IVF
Q4 25
$895.3K
Q3 25
$1.4M
$1.8M
Q2 25
$1.3M
$1.9M
Q1 25
$925.6K
$1.6M
Q4 24
$526.4K
$1.7M
Q3 24
$339.2K
$1.4M
Q2 24
$62.4K
$1.8M
Q1 24
$20.4K
$1.6M
Net Profit
AIRE
AIRE
IVF
IVF
Q4 25
$-4.8M
Q3 25
$-5.8M
$-2.6M
Q2 25
$-4.1M
$-5.3M
Q1 25
$-2.8M
$-17.4M
Q4 24
$-21.0M
$-3.6M
Q3 24
$-2.1M
$-1.6M
Q2 24
$-1.5M
$-2.2M
Q1 24
$-1.4M
$-1.6M
Gross Margin
AIRE
AIRE
IVF
IVF
Q4 25
62.7%
Q3 25
51.9%
Q2 25
49.6%
Q1 25
56.0%
35.2%
Q4 24
71.1%
41.4%
Q3 24
66.6%
31.0%
Q2 24
70.7%
53.1%
Q1 24
10.7%
45.3%
Operating Margin
AIRE
AIRE
IVF
IVF
Q4 25
-507.8%
Q3 25
-342.4%
-93.1%
Q2 25
-326.5%
-160.4%
Q1 25
-261.7%
-1042.1%
Q4 24
-524.6%
-202.0%
Q3 24
-479.1%
-90.7%
Q2 24
-1939.6%
-100.9%
Q1 24
-6397.0%
-95.7%
Net Margin
AIRE
AIRE
IVF
IVF
Q4 25
-541.6%
Q3 25
-400.1%
-150.5%
Q2 25
-328.3%
-283.6%
Q1 25
-307.9%
-1060.1%
Q4 24
-3994.4%
-211.3%
Q3 24
-618.6%
-113.8%
Q2 24
-2370.9%
-122.2%
Q1 24
-6946.9%
-101.3%
EPS (diluted)
AIRE
AIRE
IVF
IVF
Q4 25
$-0.02
Q3 25
$-0.07
$-0.77
Q2 25
$-0.08
$-13.30
Q1 25
$-0.06
$-12.53
Q4 24
$-0.47
$14.86
Q3 24
$-0.05
$-15.11
Q2 24
$-0.03
$-22.39
Q1 24
$-0.03
$-7.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIRE
AIRE
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$7.8M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$11.5M
$5.8M
Total Assets
$21.7M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIRE
AIRE
IVF
IVF
Q4 25
$7.8M
Q3 25
Q2 25
$587.3K
Q1 25
$1.2M
Q4 24
$3.1M
Q3 24
$7.1M
Q2 24
$3.7M
Q1 24
$4.8M
Total Debt
AIRE
AIRE
IVF
IVF
Q4 25
Q3 25
$2.0M
Q2 25
$152.9K
$4.8M
Q1 25
Q4 24
$241.1K
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AIRE
AIRE
IVF
IVF
Q4 25
$11.5M
Q3 25
$10.9M
$5.8M
Q2 25
$-1.1M
$2.6M
Q1 25
$-972.3K
$3.3M
Q4 24
$1.6M
$12.7M
Q3 24
$22.5M
$-23.3K
Q2 24
$22.2M
$1.4M
Q1 24
$23.3M
$10.2K
Total Assets
AIRE
AIRE
IVF
IVF
Q4 25
$21.7M
Q3 25
$19.7M
$18.8M
Q2 25
$15.5M
$19.3M
Q1 25
$18.5M
$31.7M
Q4 24
$12.0M
$46.4M
Q3 24
$34.2M
$17.0M
Q2 24
$24.6M
$17.8M
Q1 24
$25.4M
$17.3M
Debt / Equity
AIRE
AIRE
IVF
IVF
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.15×
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIRE
AIRE
IVF
IVF
Operating Cash FlowLast quarter
$-11.3M
$-1.8M
Free Cash FlowOCF − Capex
$-11.3M
$-1.8M
FCF MarginFCF / Revenue
-1262.7%
-101.6%
Capex IntensityCapex / Revenue
4.8%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-20.2M
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIRE
AIRE
IVF
IVF
Q4 25
$-11.3M
Q3 25
$-4.2M
$-1.8M
Q2 25
$-2.3M
$-1.7M
Q1 25
$-2.3M
$-3.5M
Q4 24
$-6.0M
$-617.4K
Q3 24
$-1.3M
$-640.8K
Q2 24
$-1.0M
$-1.5M
Q1 24
$-1.5M
$-260.6K
Free Cash Flow
AIRE
AIRE
IVF
IVF
Q4 25
$-11.3M
Q3 25
$-4.3M
$-1.8M
Q2 25
$-2.3M
$-1.7M
Q1 25
$-2.3M
$-3.6M
Q4 24
$-6.1M
$-696.3K
Q3 24
$-1.3M
Q2 24
$-1.5M
Q1 24
$-310.3K
FCF Margin
AIRE
AIRE
IVF
IVF
Q4 25
-1262.7%
Q3 25
-294.1%
-101.6%
Q2 25
-187.5%
-92.6%
Q1 25
-246.4%
-216.9%
Q4 24
-1150.2%
-40.6%
Q3 24
-372.2%
Q2 24
-82.3%
Q1 24
-19.7%
Capex Intensity
AIRE
AIRE
IVF
IVF
Q4 25
4.8%
Q3 25
0.4%
0.5%
Q2 25
1.1%
0.5%
Q1 25
1.5%
0.9%
Q4 24
2.4%
4.6%
Q3 24
2.2%
0.0%
Q2 24
3.0%
Q1 24
3.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons